C-Reactive Protein: An Important Inflammatory Marker of Coronary Atherosclerotic Disease

Xiaona Zhao1,2, Cheng Gao2, Hongfang Chen3

  • 1Guangxi University of Chinese Medicine, Nanning, China.

Angiology
|August 10, 2024
PubMed

Insights

C-reactive protein (CRP) is a key inflammatory biomarker that significantly elevates cardiovascular disease (CVD) risk. Research confirms CRP

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Biology
  • Biomarker Research

Background:

  • Cardiovascular disease (CVD) is a leading global cause of mortality.
  • Coronary atherosclerotic heart disease (CHD) drives most CVD events.
  • Inflammation is a critical factor in the pathogenesis of CHD.

Purpose of the Study:

  • To review the association between C-reactive protein (CRP) and cardiovascular disease (CVD).
  • To explore CRP's role in atherosclerosis (AS) and CHD development.
  • To highlight CRP's clinical utility in risk stratification and prognosis.

Main Methods:

  • Extensive literature search on PubMed.
  • Inclusion of review and research articles from January 2000 to April 2024.
  • Synthesis of evidence linking CRP to inflammation, AS, and CHD.

Main Results:

  • CRP is consistently identified as a risk enhancer for CVD.
  • CRP aids in refining risk stratification and identifying at-risk individuals.
  • CRP levels correlate with disease progression and predict recurrent cardiovascular events.

Conclusions:

  • CRP is a valuable biomarker in understanding and managing cardiovascular disease.
  • CRP's involvement in AS pathogenesis offers potential for targeted therapies.
  • CRP has significant clinical applications for risk assessment and patient management.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
121
Inflammation01:38

Inflammation

Overview
53.3K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
28